100 First Stamford Place; Suite 606
Stamford, CT 06901
Tom McCarthy, CEO – email@example.com
Spinifex Pharmaceuticals (www.spinifexpharma.com) is a cutting-edge biotech company committed to drug discovery and development leading to the commercialization of potential new treatments for chronic pain. We are backed by world class venture-capital, and have recently relocated our corporate headquarters to Stamford, Connecticut while still maintaining a presence in Australia, where the Company was founded in 2005. We have a relatively small number of full time employees, but then design, implement and manage drug discovery and development studies through a network of global specialist contractors and consultants. We are committed to growing the core team in Stamford and continuing the clinical development of EMA401 following the successful Phase 2 clinical trial of this compound in patients with postherpetic neuralgia, a type of neuropathic pain.
Discovery and clinical development of angiotensin II type 2 receptor antagonists as first in class oral treatments for chronic pain, without central nervous system side-effects.